A detailed history of First National Bank Of Omaha transactions in Abb Vie Inc. stock. As of the latest transaction made, First National Bank Of Omaha holds 7,740 shares of ABBV stock, worth $1.55 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
7,740
Previous 8,188 5.47%
Holding current value
$1.55 Million
Previous $1.49 Million 11.0%
% of portfolio
0.09%
Previous 0.1%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$154.79 - $180.76 $69,345 - $80,980
-448 Reduced 5.47%
7,740 $1.33 Million
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $24,292 - $27,679
-152 Reduced 1.82%
8,188 $1.49 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $16,512 - $18,596
-120 Reduced 1.42%
8,340 $1.29 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $82,825 - $95,883
620 Added 7.91%
8,460 $1.26 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $47,041 - $58,539
-355 Reduced 4.33%
7,840 $1.06 Million
Q1 2023

May 03, 2023

SELL
$144.61 - $166.54 $49,022 - $56,457
-339 Reduced 3.97%
8,195 $1.31 Million
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $416,036 - $498,936
-3,008 Reduced 26.06%
8,534 $1.38 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $148,033 - $169,784
1,103 Added 10.57%
11,542 $1.55 Million
Q2 2022

Sep 06, 2022

BUY
$137.62 - $174.96 $32,615 - $41,465
237 Added 2.32%
10,439 $1.6 Million
Q1 2022

May 25, 2022

SELL
$131.98 - $163.75 $121,949 - $151,305
-924 Reduced 8.3%
10,202 $1.65 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $145,460 - $184,049
1,354 Added 13.86%
11,126 $1.51 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $609,991 - $692,431
-5,733 Reduced 36.98%
9,772 $1.05 Million
Q1 2021

May 06, 2021

SELL
$102.3 - $112.62 $88,489 - $97,416
-865 Reduced 5.28%
15,505 $1.68 Million
Q4 2020

Feb 18, 2021

BUY
$80.49 - $108.67 $9,256 - $12,497
115 Added 0.71%
16,370 $1.75 Million
Q3 2020

Nov 06, 2020

SELL
$85.91 - $100.83 $49,999 - $58,683
-582 Reduced 3.46%
16,255 $1.42 Million
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $82,321 - $110,157
1,122 Added 7.14%
16,837 $1.65 Million
Q1 2020

Apr 29, 2020

SELL
$64.5 - $97.79 $70,627 - $107,080
-1,095 Reduced 6.51%
15,715 $1.2 Million
Q4 2019

Jan 17, 2020

BUY
$72.13 - $90.25 $78,982 - $98,823
1,095 Added 6.97%
16,810 $1.49 Million
Q3 2019

Nov 04, 2019

SELL
$62.98 - $75.72 $88,172 - $106,008
-1,400 Reduced 8.18%
15,715 $1.19 Million
Q2 2019

Jul 10, 2019

BUY
$65.7 - $83.98 $2,299 - $2,939
35 Added 0.2%
17,115 $1.24 Million
Q1 2019

May 01, 2019

SELL
$77.14 - $90.79 $49,292 - $58,014
-639 Reduced 3.61%
17,080 $1.38 Million
Q4 2018

Jan 23, 2019

BUY
$77.85 - $96.01 $1.38 Million - $1.7 Million
17,719 New
17,719 $1.63 Million
Q4 2018

Jan 22, 2019

SELL
$77.85 - $96.01 $1.46 Million - $1.8 Million
-18,715 Closed
0 $0
Q3 2018

Nov 05, 2018

BUY
$88.91 - $98.84 $4,000 - $4,447
45 Added 0.24%
18,715 $1.77 Million
Q2 2018

Jul 12, 2018

SELL
$89.78 - $106.23 $15,711 - $18,590
-175 Reduced 0.93%
18,670 $1.73 Million
Q1 2018

May 03, 2018

BUY
$92.01 - $123.21 $7,360 - $9,856
80 Added 0.43%
18,845 $1.78 Million
Q4 2017

Feb 05, 2018

BUY
$89.56 - $98.21 $1.68 Million - $1.84 Million
18,765
18,765 $1.82 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First National Bank Of Omaha Portfolio

Follow First National Bank Of Omaha and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Of Omaha, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Of Omaha with notifications on news.